Lululemon Athletica Inc (LULU) Stock Price Today
Aura AI Summary
Key Stats
- $13.23BMarket Cap
- -Volume
- Consumer CyclicalSector
- $236.5152W High
- $105.4352W Low
- -Typical Hold Time
- $13.85BEnterprise Value
- -Div Yield
- -Trading Activity
Track Lululemon Athletica Inc (LULU) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Lululemon Athletica Inc has traded between a low of $105.43 and a high of $236.51, highlighting its annual price range. Buy and sell Lululemon Athletica Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Lululemon Athletica Inc
Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Most Recent News
Renewed U.S.-Iran tensions push oil prices up, impacting key economic sectors and confirming AI investment confidence.
Renewed hostilities between the U.S. and Iran, including attacks on commercial vessels in the Strait of Hormuz and reinstated U.S. sanctions on Iran, caused crude oil prices to rise sharply. This increase pressured economically sensitive sectors such...

Alamar Biosciences' NULISA platform featured in 140+ studies at AAIC 2026, advancing blood-based Alzheimer's biomarker detection.
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...

Alamar Biosciences showcases over 140 presentations on blood-based Alzheimer's biomarkers at AAIC 2026.
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...
